¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tissue inhibitors of metalloproteinase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® connective tissue ÇÑ±Û °áÇÕÁ¶Á÷
¼³¸í   
  Ã¼³»¿¡ ³Î¸® ºÐÆ÷Çϸç, Àå±â, Á¶Á÷»çÀ̸¦ ¸Þ¿ì°í ±×°ÍÀ» ±â°èÀûÀ¸·Î ÁöÁö, Á¶Á÷ÀÌ´Ù. ±×¹Û¿¡ Ç÷°ü, ¸²ÇÁ°ü, ½Å°æÀ» ÀεµÇϸ砿µ¾ç, ´ë»ç»ê¹°ÀÇ ¼ö¼Û ¶Ç´Â Àú·ù, ³ª¾Æ°¡¼­´Â ¼Õ»ó, °¨¿°¿¡ ´ëÇÑ ¹æ¾î ¶Ç´Â ¼öº¹ µî¿¡µµ ÀÛ¿ëÇÑ´Ù. °áÇÕÁ¶Á÷Àº ¼¼Æ÷°£ÁúÀ̠dzºÎÇϸç, ¼¼Æ÷°£ÁúÀ» ±¸¼ºÇϴ ±âÁú°ú ¼¶À¯ÀÇ ¼º»ó¿¡ µû¶ó °£¿±Á¶Á÷, ¼¶À¯¼º °áÇÕÁ¶Á÷(¼º±ä¼¶À¯¼º °áÇÕÁ¶Á÷, ÃÎÃÎÇÑ ¼¶À¯¼º °áÇÕÁ¶Á÷), Áö¹æÁ¶Á÷, Åº¼ºÁ¶Á÷, ¼¼¸Á Á¶Á÷ µîÀ¸·Î ºÐ·ùµÈ´Ù.
  
  
¿µ¹® osseous tissue ÇÑ±Û »ÀÁ¶Á÷, °ñÁ¶Á÷
¼³¸í   
  °ñ¼¼Æ÷¿Í °ñ¼¼Æ÷ÁÖÀ§ÀÇ µüµüÇÑ Ä®½·Á¶Á÷À¸·Î µÑ·¯½ÎÀΠ¹ÐÁýµÈ °áÇÕÁ¶Á÷À» ¶æÇÑ´Ù. ÀÌ °ñÁ¶Á÷¿¡ ÀÇÇØ¼­ »À°¡ ÀÌ·ç¾îÁ® ÀÎüÀÇ °ñ°ÝÀ» Çü¼ºÇÑ´Ù.
¿µ¹® epithelial tissue ÇÑ±Û »óÇÇÁ¶Á÷
¼³¸í   
  »óÇǴ ÇÑ Ãþ ¶Ç´Â ¿©·¯ ÃþÀÇ ¼¼Æ÷·Î ÀÌ·ç¾îÁø ÆÇ ¸ð¾çÀÇ ±¸Á¶·Î ½ÅüÀǠǥ¸é°ú °ü»ó±¸Á¶ÀÇ ³»°­À» µÑ·¯½Î°í ÀÖ´Ù. »óÇǼ¼Æ÷¿Í »óÇǼ¼Æ÷»çÀÌÀÇ ÀûÀº ¾çÀ¸·Î Á¸ÀçÇÏ¿© »óÇÇ»çÀÌÀÇ °ø°£À» Ã¤¿ì°í Àִ ¼¼Æ÷°£ÁúÀ» ÇÕÃÄ »óÇÇÁ¶Á÷À̶ó ÇÑ´Ù. »óÇÇÁ¶Á÷¿¡´Â ¿øÄ¢ÀûÀ¸·Î Ç÷°üÀÌ ºÐÆ÷µÇ¾î ÀÖÁö ¾Ê´Ù.
¿µ¹® granulation tissue ÇÑ±Û À°¾ÆÁ¶Á÷
¼³¸í   
  ¸ð¼¼Ç÷°üÀ̠dzºÎÇϸ砿ռºÇϰԠÁõ½ÄÀ» °è¼ÓÇϴ ¾î¸° °áÇÕÁ¶Á÷. Ã¢»ó µî Á¶Á÷ °á¼Õ¿¡ ´ëÇÑ ¼öº¹, À̹°Ã³¸®ÀÇ ±âÁúÈ­, ¿°ÁõÀÌ ¸¸¼ºÀûÀΠ°æ°ú¿¡ Àְųª Á¾¾çÁõ½Ä¿¡ µ¿¹ÝµÈ »çÀ̹°ÁúÀÇ ¹ÝÀÀ¼º ¿°Áõ¿¡¼­ °üÂûµÈ´Ù. ±¸¼º¼ººÐÀº »ý±äÁö ¾ó¸¶ ¾ÈµÇ´Â ¾î¸° À°¾ÆÁ¶Á÷Àº ¼¶À¯¸ð¼¼Æ÷ÀÇ Áõ½Ä, »õ·Î »ý±ä ¸ð¼¼Ç÷°ü°ú ¿©·¯ À¯ÁÖ¼¼Æ÷ ¹× ´Ù¸¥ Áß°£¿±¼¼Æ÷(¹éÇ÷±¸, ¸²ÇÁ±¸, ÇüÁú¼¼Æ÷, Á¶Á÷±¸, ´ÜÇÙ±¸, °Å´ë¼¼Æ÷)µîÀ¸·Î ±¸¼ºµÈ´Ù. À̰ÍÀÌ ½Ã°£ÀÌ Áö³ª ±×¸®µÇ¸é, ¸ð¼¼Ç÷°ü°ú À¯ÁÖ¼¼·Î, ´Ù¸¥Á¶Á÷¼ººÐÀ» °¨¼Ò½ÃÄÑ ¸¸¼ºÈ­ÇÏ¿© ¿À·¡µÈ À°¾Æ°¡ µÇ¸ç °á±¹Àº ¼¶À¯¼¼Æ÷¿Í ¾Æ±³Áú¼¶À¯·Î ±¸¼ºµÈ ¹ÝÈçÁ¶Á÷À¸·Î º¯ÇÑ´Ù.
¿µ¹® tissue ÇÑ±Û Á¶Á÷
¼³¸í   
  Æ¯Á¤ ±¸Á¶¿Í ±â´ÉÀ» °®´Â ¼¼Æ÷ Áý´Ü. ¼¼Æ÷ »çÀÌ¿¡´Â ´Ù¼Ò°£ ¼¼Æ÷°£ÁúÀÌ µé¾î ÀÖ´Ù. ¼¼Æ÷°£Áú¿¡´Â ±Û¸®ÄÚ»ç¹Ì³ë±Û¸®Ä­, È÷µå·Ï½Ã¾ÆÆÄŸÀÌÆ®¿Í °°Àº ±âÁú°ú ¾Æ±³Áú¼¶À¯¿Í °°Àº ¼¶À¯°¡ ¹ß°ßµÈ´Ù. Á¶Á÷¼º»óÀº ±¸¼º¼¼Æ÷¿Í ¼¼Æ÷°£ÁúÀÇ Á¾·ù¿Í ¾ç¿¡ ÀÇÇØ °áÁ¤µÈ´Ù. Á¶Á÷Àº »óÇÇÁ¶Á÷, ÁöÁöÁ¶Á÷, ±ÙÀ°Á¶Á÷, ½Å°æÁ¶Á÷À¸·Î ´ëº°µÇ¸ç, »óÇÇÁ¶Á÷Àº ¼¼Æ÷°£ÁúÀ» °ÅÀÇ °®Áö ¾ÊÀ¸¸ç, ÁöÁöÁ¶Á÷Àº °áÇÕÁ¶Á÷À̳ª »ÀÁ¶Á÷°ú °°ÀÌ ¼¼Æ÷°£ÁúÀ̠dzºÎÇÑ °ÍÀÌ ¸¹´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-lactamase inhibitors
    º£Å¸¶ô޾ÆÁ¦¾ïÁ¦Á¦
  • metalloproteinase
    ±Ý¼Ó´Ü¹éºÐÇØÈ¿¼Ò
  • areolar tissue
    ¼º±ÙÁ¶Á÷
  • adipose tissue
    Áö¹æÁ¶Á÷
  • compact tissue
    Ä¡¹ÐÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue cell
    °áÇÕÁ¶Á÷¼¼Æ÷
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • connective tissue fiber
    °áÇÕÁ¶Á÷¼¶À¯
  • connective tissue nevus
    °áÇÕÁ¶Á÷¸ð¹Ý
  • elastic tissue
    ź·ÂÁ¶Á÷
  • epithelial tissue
    »óÇÇÁ¶Á÷
  • erectile tissue
    ¹ß±âÁ¶Á÷
  • granulation tissue
    À°¾ÆÁ¶Á÷
  • gut-associated lymphatic tissue
    âÀÚ¿¬°ü¸²ÇÁÁ¶Á÷, À忬°ü¸²ÇÁÁ¶Á÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metalloproteinase
    ±Ý¼Ó´Ü¹éºÐÇØÈ¿¼Ò
  • tissue plasminogen activator
    Á¶Á÷Çö󽺹̳ë°ÕȰ¼ºÁ¦
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • tissue
    Á¶Á÷
  • adipose tissue
    Áö¹æÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
  • elastic tissue
    ź·ÂÁ¶Á÷
  • erectile tissue
    ¹ß±âÁ¶Á÷
  • granulation tissue
    À°¾ÆÁ¶Á÷
  • interstitial tissue
    »çÀÌÁúÁ¶Á÷, °£ÁúÁ¶Á÷
  • lymphatic tissue
    ¸²ÇÁÁ¶Á÷
  • mesenchymal tissue
    Áß°£¿±Á¶Á÷
  • muscular tissue
    ±ÙÀ°Á¶Á÷
  • nervous tissue
    ½Å°æÁ¶Á÷
  • osseous tissue
    »ÀÁ¶Á÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metalloproteinase
    ±Ý¼Ó´Ü¹éºÐÇØÈ¿¼Ò
  • acute normal tissue effect
    Á¤»óÁ¶Á÷±Þ¼º¿µÇâ
  • adipose tissue
    Áö¹æÁ¶Á÷
  • tissue antibody
    Á¶Á÷Ç×ü
  • tissue biopsy
    Á¶Á÷»ý°Ë
  • compact tissue
    Ä¡¹ÐÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
  • connective tissue cell
    °áÇÕÁ¶Á÷¼¼Æ÷
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • connective tissue fiber
    °áÇÕÁ¶Á÷¼¶À¯
  • connective tissue nevus
    °áÇÕÁ¶Á÷¸ð¹Ý
  • soft tissue coverage
    ¿¬Á¶Á÷ÇǺ¹
  • tissue characterization
    Á¶Á÷Ư¼º°¨º°
  • tissue conduction
    Á¶Á÷Àüµµ
  • tissue contrast
    Á¶Á÷´ëÁ¶µµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prostease inhibitors
    ´Ü¹éºÐÇØÈ¿¼Ò¾ïÁ¦¹°(Áú)(Ó±ÛÜÝÂú°ý£áÈåäð¤Úª(òõ)), ÇÁ·ÎÅ׿¡¿¡½º¾ïÁ¦¹°
  • Connetive tissue
    °áÇÕÁ¶Á÷(Ì¿ùêðÚòÄ)
  • Macrophages tissue
    ´ë½Ä¼¼Æ÷Á¶Á÷(ÓÞãÝá¬øàðÚòÄ)
  • abnormality of tissue
    Á¶Á÷ÀÌ»ó
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • angioblastic tissue
    Ç÷°ü¹ß»ýÁ¶Á÷
  • free water in stationary tissue
    Á¤Àû Á¶Á÷³» ÀÚÀ¯ ¼öºÐ
  • general connective tissue
    ÀϹݰáÇÕÁ¶Á÷.
  • gingival tissue esthetics
    Ä¡ÀºÁ¶Á÷½É¹Ì¼º.
  • granulation tissue
    À°¾ÆÁ¶Á÷(¡­ðÚòÄ)
  • gut-associated lymphatic tissue (GALT)
    Àå-¿¬°ü ¸²ÇÁÁ¶Á÷
  • hemopoietic tissue
    Ç÷__ü¼ºÁ¶Á__ Á¶Ç÷Á¶Á÷.
  • hemopoietic tissue
    Ç÷±¸Çü¼ºÁ¶Á÷
  • hemopoietic tissue
    Ç÷±¸Çü¼ºÁ¶Á÷, Á¶Ç÷Á¶Á÷.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tissue inhibitor of metalloproteinase
    ±Ý¼Ó´Ü¹éºÐÇØÈ¿¼Ò
  • metalloproteinase
    ±Ý¼Ó´Ü¹éºÐÇØÈ¿¼Ò(ÐÝáÕÓ±ÛÜÝÂú°ý£áÈ)
  • beta-lactamase inhibitors
    º£Å¸-¶ôޯı«È¿¼Ò¾ïÁ¦Á¦.
  • clotting inhibitors
    ÀÀ°í¾ïÁ¦Á¦(ëêͳåäð¤ð¥)
  • monoamine oxidase(MAO) inhibitors
  • mucociliary inhibitors
    Á¡¾×¼¶¸ð ¾ïÁ¦ÀÎÀÚ(¡­àéÙ¾ åäð¤ì×í­)
  • prostease inhibitors
    ´Ü¹éºÐÇØÈ¿¼Ò¾ïÁ¦¹°(Áú)(Ó±ÛÜÝÂú°ý£áÈåäð¤Úª(òõ)), ÇÁ·ÎÅ׿¡¿¡½º¾ïÁ¦¹°
  • spongy bone tissue [trabecular bone tissue]
    ÇØ¸é»ÀÁ¶Á÷
  • abnormality of tissue
    Á¶Á÷ÀÌ»ó
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • angioblastic tissue
    Ç÷°ü¹ß»ýÁ¶Á÷
  • bone tissue
    »ÀÁ¶Á÷, °ñÁ¶Á÷(ÍéðÚòÄ).
  • bone tissue
    »ÀÁ¶Á÷
  • bone-soft tissue interface
    °ñ¿¬ºÎÁ¶Á÷°æ°è¸é, °ñ¿¬ºÎÁ¶Á÷°øÀ¯¸é
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Spongy bone tissue [Trabecular bone tissue]
    ÇØ¸é»ÀÁ¶Á÷
    [¿¾ ¿ë¾î] ÇØ¸é°ñÁ¶Á÷
  • Skeletal muscular tissue
    °¡·Î¹«´Ì±ÙÀ°Á¶Á÷ [»À´ë±ÙÀ°Á¶Á÷]
    [¿¾ ¿ë¾î] °ñ°Ý±ÙÁ¶Á÷
  • Brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
    [¿¾ ¿ë¾î] °¥»öÁö¹æÁ¶Á÷
  • Subconjunctival tissue
    °á¸·¹ØÁ¶Á÷
    [¿¾ ¿ë¾î] °á¸·ÇÏÁ¶Á÷
  • Lymphoblastic tissue
    ¸²ÇÁ°ü¹ß»ýÁ¶Á÷
    [¿¾ ¿ë¾î] ÀÓÆÄ¸ð¼¼Æ÷Á¶Á÷
  • Smooth musclular tissue
    ¹Î¹«´Ì±ÙÀ°Á¶Á÷ [³»Àå±ÙÀ°Á¶Á÷]
    [¿¾ ¿ë¾î] ÆòȰ±ÙÁ¶Á÷
  • White fat tissue
    ¹é»öÁö¹æÁ¶Á÷
    [¿¾ ¿ë¾î] ¹é»öÁö¹æÁ¶Á÷
  • Loose collagenous connective tissue
    ¼º±ä¾Æ±³°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼Ò¼º°áÇÕÁ¶Á÷
  • Reticular connective tissue
    ¼¼¸Á°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼¸Á°áÇÕÁ¶Á÷
  • Reticular tissue
    ¼¼¸ÁÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼¸ÁÁ¶Á÷
  • Cellular connective tissue
    ¼¼Æ÷¼º°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º°áÇÕÁ¶Á÷
  • Neural crest tissue
    ½Å°æ´É¼±Á¶Á÷
    [¿¾ ¿ë¾î] ½Å°æ¸ªÁ¶Á÷
  • Tissue of neural crest (Mesectoderm)
    ½Å°æ´É¼±Á¶Á÷ (Áß°£¿Ü¹è¿±)
    [¿¾ ¿ë¾î] ½Å°æ¸ªÁ¶Á÷
  • Nervous tissue (Neuroblastoma)
    ½Å°æÁ¶Á÷ (½Å°æ¸ð¼¼Æ÷Á¾)
    [¿¾ ¿ë¾î] ½Å°æÁ¶Á÷
  • Cardiac muscular tissue
    ½ÉÀå±ÙÀ°Á¶Á÷
    [¿¾ ¿ë¾î] ½É±ÙÁ¶Á÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilharzial granulation tissue
    ¹æ±¤ÁÖÇ÷ÈíÃæÀ°¾ÆÁ¶Á÷
  • tissue parasite
    Á¶Á÷±â»ýÃæ
  • tissue selectivity
    Á¶Á÷¼±Åüº
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adipose tissue
    Áö¹æÁ¶Á÷(ò·Û¸ðÚòÄ)
  • brown adipose tissue
    °¥»öÁö¹æÁ¶Á÷(Êèßäò·Û¸ðÚòÄ)
  • established tissue chluture
    ¼ö¸³ Á¶Á÷¹è¾ç (â§Ø¡ðÚòÄÛÆå×)
  • lipoprotein tissue factor
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ) Á¶Á÷ÀÎÀÚ(ðÚòÄì×í­)
  • median tissue culture dose
    Á¤ÁßÁ¶Á÷¹è¾ç·®(ïáñéðÚòÄÛÆå×Õá)
  • primary tissue culture
    ÀÏÂ÷ Á¶Á÷¹è¾ç(ìéó­ðÚòÄÛÆå×)
  • tissue culture
    Á¶Á÷¹è¾ç (ðÚòÄÛÆå×)
  • tissue culture infectious dose
    Á¶Á÷¹è¾ç °¨¿°·® (ðÚòÄÛÆå×ÊïæøÕá)
  • tissue factor
    Á¶Á÷ÀÎÀÚ (ðÚòÄì×í­)
  • tissue hormone
    Á¶Á÷(ðÚòÄ)È£¸£¸ó
  • tissue plasminogen activator
    Á¶Á÷(ðÚòÄ)Çö󽺹̳ëÀü Ȱ¼ºÀÚ (üÀàõí­)
  • tissue polypeptide antigen
    Á¶Á÷(ðÚòÄ)Æú¸®ÆéŸÀ̵å Ç׿ø (ù÷ê«)
  • tissue slice
    Á¶Á÷ õ¿± (ðÚòÄô¼ç¨)
  • tissue-specific enzyme
    Á¶Á÷ ƯÀÌ È¿¼Ò (ðÚòÄ÷åì¶ý£áÈ)
  • tissue thromboplastin
    Á¶Á÷(ðÚòÄ)Æ®·Òº¸ÇÃ¶ó½ºÆ¾
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aberrant breast tissue
    ¹ÌÀÔÀ¯¹æÁ¶Á÷
  • areolar tissue
    À±¹®»óÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
  • fibrous tissue
    ¼¶À¯¼ºÁ¶Á÷
  • flowing tissue
    À¯µ¿Á¶Á÷, ±â·ù¼ºÁ¶Á÷
  • free water in stationary tissue
    Á¤ÀûÁ¶Á÷³» ÀÚÀ¯¼öºÐ
  • granulation tissue
    À°¾ÆÁ¶Á÷
  • inflammatory tissue
    ¿°ÁõÁ¶Á÷
  • interstitial tissue
    °£ÁúÁ¶Á÷
  • lattice in stationary tissue
    Á¤ÀûÁ¶Á÷³»°ÝÀÚ
  • MALT(mucosa associated lymphoid tissue)
    Á¡¸·°ü·Ã¸²ÇÁÁ¶Á÷
  • mesenchymal tissue
    Áß°£¿±Á¶Á÷, °£¿±Á¶Á÷
  • muscle tissue
    ±ÙÀ°Á¶Á÷, ±ÙÁ¶Á÷
  • osseous tissue
    »ÀÁ¶Á÷, °ñÁ¶Á÷
  • osteoblastic tissue
    °ñÇü¼ºÁ¶Á÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAOI MonoAmine Oxidase Inhibitors
MMP matrix metalloproteinase; muscle mechanical power
MMPI matrix metalloproteinase specific for collagen type I; Minnesota Multiphasic Personality Inventory
PUMP putative metalloproteinase
ABCDES abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TIMP-2 Tissue Inhibitor of Metalloproteinase 2
TIMP-1 Tissue inhibitor of matrix metalloproteinase-1
TIMP-1 Tissue inhibitor of metalloproteinase 1
TIMP-3 Tissue inhibitor of metalloproteinase-3
AChE-I acetylcholine esterase inhibitors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • metalloproteinase
    ±Ý¼Ó ´Ü¹é ºÐÇØ È¿¼Ò
  • aberrant breast tissue
    ¹ÌÀÔ À¯¹æ Á¶Á÷
  • absorptive tissue
    Èí¼ö Á¶Á÷
  • acute and late normal tissue effects£¨Á¤»ó Á¶Á÷ ±Þ¼º ¿µÇ⣩

    acute angle

    ¿¹°¢
    Á÷°¢º¸´Ù ÀÛÀº °¢.
  • adenoid tissue
    ¾Æµ¥³ëÀ̵å Á¶Á÷
  • adipose tissue disease
    Áö¹æ Á¶Á÷ Áúȯ
  • bone tissue
    »À Á¶Á÷, °ñ Á¶Á÷
  • bony tissue
    °ñ¼º Á¶Á÷
  • border tissue movement
    º¯¿¬ Á¶Á÷ ¿îµ¿
  • calcified tissue
    ¼®È¸È­ Á¶Á÷
    ¼®È¸È­°¡ ÀϾ Á¶Á÷.
  • cartilage tissue
    ¿¬°ñ Á¶Á÷, ¹°··»À Á¶Á÷
    »À ¸»´Ü¿¡ Àִ ź·Â¼º ÀÖ´Â °áÇÕÁ¶Á÷À̸ç, »À Ç¥¸éÀ» ½Ñ´Ù. ÅÂ¾Æ °ñ°Ý, ´Á°ñ, ºñ Áß°Ý, ¿ÜÀÌ¿¡µµ Á¸Àç.
  • cellular connective tissue
    ¼¼Æ÷¼º °áÇÕ Á¶Á÷
    ¼¼Æ÷·Î »çÀ̰¡ ¿¬°áµÇ¾î ÀÖ´Â Á¶Á÷.
  • cementoid tissue
    ¹é¾ÇÁú¾ç Á¶Á÷
  • chromaffin tissue
    Å©·Ò ģȭ Á¶Á÷
  • compact tissue
    Ä¡¹Ð Á¶Á÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
tissue inhibitors of metalloproteinase <cell biology> Family of proteins of around 200 residues that can inhibit metalloproteinases, for example collagenase, by binding to them.
(18 Nov 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
tissue-inhibitor of metalloproteinase-1 <chemical> A member of the family of tissue inhibitor of metalloproteinases. It is a n-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumour invasion in vitro.
Pharmacological action: antineoplastic agent, protease inhibitors.
(12 Dec 1998)
tissue inhibitor-of metalloproteinase-2 <chemical> A member of the family of tissue inhibitor of metalloproteinases. It is a 21 kD nonglycosylated protein found in tissue fluid and is secreted as a complex with progelatinase a by human fibroblast and uncomplexed from alveolar macrophages. An overexpression of timp-2 has been shown to inhibit invasive and metastatic activity of tumour cells and decrease tumour growth in vivo.
Pharmacological action: antineoplastic agent, protease inhibitors.
(12 Dec 1998)
tissue inhibitor of-metalloproteinase-3 <chemical> A member of the family of tissue inhibitor of metalloproteinases. It is a 21 kD, nonglycosylated protein. Timp-3 does not show a high degree of structural similarity unlike timp-1 and timp-2 which are structurally similar. However, it does possess a high degree of structural similarity with that of chicken timp-3 (chimp-3). Human timp-3 is of particular concern because of its potential role in cancer, arthritis, and eye diseases.
Pharmacological action: antineoplastic agent, protease inhibitors.
(12 Dec 1998)
Aspergillus fumigatus metalloproteinase <enzyme> Mol mass 82 kD; pi 5.6; hydrolyzes phenylazobenzyloxycarbonyl-pro-leu-gly-pro-arg and cleaves native rat type I collagen
Registry number: EC 3.4.24.-
Synonym: a. Fumigatus metalloproteinase, af-mep
(26 Jun 1999)
BaP1 metalloproteinase <enzyme> From bothrops asper venom; causes haemorrhage at site of venom injection and systemically in different organs
Registry number: EC 3.4.24.-
(26 Jun 1999)
membrane-type 3 matrix metalloproteinase <enzyme> Sm3 is a soluble form of mt3-mmp, probably an alternatively sliced variant.
Registry number: EC 3.4.24.-
Synonym: mt3-mmp, sm3-mmp
(26 Jun 1999)
membrane-type 4 matrix metalloproteinase <enzyme> Cloned from breast carcinoma.
Registry number: EC 3.4.24.-
Synonym: mt4-mmp, mmp-17 gene product, mmp-17
(26 Jun 1999)
membrane-type matrix metalloproteinase <enzyme> Activates gelatinase a; isolated from a human placenta cdna gene library; contains a transmembrane domain; do not use for any other numbered matrix metalloproteinases; genbank d26512
Registry number: EC 3.4.24.-
Synonym: mt-mmp, mmp-x1 protein, matrix metalloproteinase, membrane-type, mmp14 gene product, mmp-14 gene product, mt1-mmp, matrix metalloproteinase 14, mt2-mmp, mmp15 gene product, mmp16 gene product
(26 Jun 1999)
haemorrhagic metalloproteinase <enzyme> Extracted from vipera berus berus venom; hydrolyzes casein, fibrinogen and splits the insulin b chain at positions ala(14)-leu(15), tyr(16)-leu(17), his(10)-leu(11); digests alpha chain of fibrinogen
Registry number: EC 3.4.24.-
(26 Jun 1999)
Xolloid metalloproteinase <enzyme> Tolloid-like protein from xenopus with development-regulating activity; acts as a ventralizing agent that mimics low doses of bone morphogenetic protein-4
Registry number: EC 3.4.24.-
Synonym: xolloid gene product
(26 Jun 1999)
S. marcescens minor metalloproteinase <enzyme> Precursor protein consists of 352 amino acids, mw 38.479 kD from serratia marcescens; mature protein consists of 300 amino acids mw 32.515 kD with optimal activity at pH 8.0 and 50c; do not confuse with smp protein, a membrane protein from E coli
Registry number: EC 3.4.24.-
Synonym: smp proteinase
(26 Jun 1999)
Streptococcus faecalis metalloproteinase <enzyme> Bacterial metalloproteinase from streptococcus faecalis
Registry number: EC 3.4.24.-
Synonym: streptococcus faecalis metalloendopeptidase, metalloproteinase (streptococcus faecalis), sf-metalloproteinase
(26 Jun 1999)
adrenergic uptake inhibitors Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (antidepressive agents, tricyclic) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.
(12 Dec 1998)
blood coagulation factor inhibitors Substances, usually endogenous, that act as inhibitors of blood coagulation. They may affect one or multiple enzymes throughout the process. As a group, they also inhibit enzymes involved in processes other than blood coagulation, such as those from the complement system, fibrinolytic enzyme system, blood cells, and bacteria.
(12 Dec 1998)
Bowman Birk protease inhibitors <pharmacology> Family of serine protease inhibitors found in seeds of leguminous plants and cereals.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tissue
    Á¶Á÷
  • cleansing tissue
    È­Àå¿ë ¹Ú¿±Áö(Ƽ½´ ÆäÀÌÆÛ)
  • connective tissue
    °áÇÕ Á¶Á÷
  • facial tissue
    °í±Þ È­ÀåÁö
  • permanent tissue
    ¿µ±¸ Á¶Á÷
  • tissue
    Á¶Á÷;¾ãÀº Á÷¹°;(°ÅÁþ¸» µûÀ§ÀÇ)µÚ¹ü¹÷;¿¬¼Ó;ź¼Ò ÀÎÈ­Áö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á